Guiping Zhang

发表

Integrated in silico–in vitro screening of ovarian cancer peroxisome proliferator-activated receptor-γ agonists against a biogenic compound library

Guiping Zhang, Feng-ying Liu, Jing Zhang, 2017, Medicinal Chemistry Research.

Design of fluorinated cyclopropane derivatives of 2-phenylcyclopropylmethylamine leading to identification of a selective serotonin 2C (5-HT2C) receptor agonist without 5-HT2B agonism.

B. Roth, Guiping Zhang, A. Kozikowski, 2019, European journal of medicinal chemistry.

Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X Syndrome.

M. Pardo, Guiping Zhang, R. Jope, 2018, ACS chemical neuroscience.

Tetrahydroquinoline-Capped Histone Deacetylase 6 Inhibitor SW-101 Ameliorates Pathological Phenotypes in a Charcot-Marie-Tooth Type 2A Mouse Model.

Guiping Zhang, B. Langley, A. Kozikowski, 2021, Journal of medicinal chemistry.

Discovery of N-Substituted (2-Phenylcyclopropyl)methylamines as Functionally Selective Serotonin 2C Receptor Agonists for Potential Use as Antipsychotic Medications.

B. Roth, Guiping Zhang, A. Kozikowski, 2017, Journal of medicinal chemistry.

Discovery of a New Isoxazole-3-hydroxamate Based Histone Deacetylase 6 Inhibitor SS-208 with Anti-tumor Activity in Syngeneic Melanoma Mouse Models.

Guiping Zhang, A. Kozikowski, C. Zimprich, 2019, Journal of medicinal chemistry.

Profiling of miRNA expression in immune thrombocytopenia patients before and after Qishunbaolier (QSBLE) treatment.

N. Narisu, Guiping Zhang, Haihua Bai, 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Rational Design of Suprastat, a Novel Selective Histone Deacetylase 6 Inhibitor with the Ability to Potentiate Immunotherapy in Melanoma Models.

G. M. Ferreira, Guiping Zhang, J. Stránský, 2020, Journal of medicinal chemistry.

Unraveling the molecular mechanism of BNC105, a phase II clinical trial vascular disrupting agent, provides insights into drug design.

Guiping Zhang, Weimin Li, Chengyong Wu, 2020, Biochemical and biophysical research communications.

An update on the discovery and development of reversible covalent inhibitors

Guiping Zhang, Faridoon, J. Li, 2023, Medicinal Chemistry Research.

Medicinal chemistry insights into non-hydroxamate HDAC6 selective inhibitors

Guiping Zhang, Faridoon, J. Li, 2022, Medicinal Chemistry Research.